$Hims & Hers Health Inc.(HIMS)$ This will definitely affect the sale of non FDA approved compounded obesity drugs sold by this company. Whatch out for a big drop in stock price if the market comes to recognize it. Any slowing of sales of the compounded drug sold by this company and memebership growth during the upcoming earnings can easily take stock down to 30s.
https://seekingalpha.com/news/4501832-novo-to-offer-wegovy-ozempic-half-price-costco
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments